STADA Georgia
Almaty, April 20, 2026 — STADA is strengthening its presence in Eurasia by entering into a strategic agreement with Church & Dwight (C&D), the owner of a portfolio of globally recognized brands. Under the agreement, STADA will undertake the launch, promotion, and distribution of a number of C&D’s popular consumer brands across nine countries in the Eurasian region.
Read more →
Bad Vilbel, Germany/London, UK – 31 March 2026 – CapVest Partners LLP (“CapVest”), a leading global investment firm, today announces the completion of its acquisition of the majority stake in STADA Arzneimittel AG (“STADA” or the “Company”), a leading healthcare and pharmaceuticals company specializing in Consumer Healthcare, Generics and Specialty Pharmaceuticals.
Read more →
Bad Vilbel, Germany – 18 March 2026 – STADA in 2025 again demonstrated the success of its three-segment strategy, that provides patients and healthcare professionals with a broad range of medicines and healthcare products across Consumer Healthcare, Generics and Specialty, including innovative medicines.
Read more →